Bioaxial develops new technologies for fluorescence microscopy to improve extended imaging of live cells.
Bioaxial has raised €2.4M across 1 funding round from 1 investor, most recently a round in Nov 2013. Based in Paris, France; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-11-01 | Other | €2.4M |
| CEA Investissement |
| View deal → |
